SHIH-CHI KU
古世基
Loading...
| Organization | Role |
Clinical Associate Professor | |
Attending Physician |
Email
scku1015@gmail.com
ORCID
Scopus Author ID
Division
Research Interests
Internal Medicine
Pulmonary and Critical Care Medicine
Ultrasound in Respiratory System
Sleep Disorder Breathing
Organization
| Organization | Major | Role | Start | End |
University of Washington | Department of Health Services, School of Public Health and Communication Medicine | Master of Public Health | January 2002 | December 2004 |
Chung Shan Medical University | School of Medicine, College of Medicine | M.D. |
Organization
| Organization | Dept | Title | Start |
National Taiwan University | Department of Internal Medicine | Clinical Associate Professor | August 2022 |
National Taiwan University Hospital | Division of Chest Medicine, Department of Internal Medicine | Attending Physician | August 2004 |
Organization
| Organization | Dept | Title | Start | End |
National Taiwan University | Department of Internal Medicine, College of Medicine | Clinical Assistant Professor | August 2014 | July 2022 |
Harborview Medical Center | Majored in the Patient Care of Intensive Care Unit | Visiting Scholar | January 2002 | December 2004 |
Far Eastern Memorial Hospital | Division of Chest, Department of Internal Medicine | Attending Physician | August 1999 | July 2001 |
Taoyuan General Hospital | Division of Chest, Department of Internal Medicine | Attending Physician | August 1999 | July 2001 |
National Taiwan University Hospital | Division of Chest, Department of Internal Medicine | Fellowship in Division of Chest | August 1997 | July 1999 |
National Taiwan University Hospital | Division of Chest, Department of Internal Medicine | Chief Resident | August 1996 | July 1997 |
National Taiwan University Hospital | Department of Internal Medicine | Resident | August 1994 | July 1996 |
Achievement(s)
A prospective, controlled, randomised, open, multicentre, multinational study comparing the efficacy and safety of I\\V to oral ciprofloxacin plus amikacin versus I\\V ceftazidime plus amikacin for the treatment of hospital-acquired pneumonia, Bayer (Singapore) Pte. Ltd., BAY q 3939/0576/ BAY o 9867/1467 OKE22, co-investigator, in Feb 1998
Oxis® and pulmicort turbuhaler® in the management of asthma (OPTIMA), co-investigator in March 1998
King County Acute Lung Injury Study (KCLIP), the survival outcome study of acute lung injury and acute respiratory distress syndrome, Harborview Medical Center, University of Washington, 2002-2004
Unscheduled Readmission of Critically ill Patients, the risk factors and its impact on their outcomes, National Taiwan University Hospital, 2004- present